Kurt Von Emster - Oct 12, 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: Director
Signature: By: /s/ Jeet Mahal, as Attorney-in-Fact
Stock symbol: JSPR
Transactions as of: Oct 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 10/13/2022, 08:05 PM
Previous filing: Mar 23, 2022
Next filing: Jan 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JSPR	Voting Common Stock	Award	$0	+30.3K		$0.00	30.3K	Oct 12, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units (the "RSU Award"), 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Remarks:

The Reporting Person is no longer deemed to share an indirect pecuniary interest in the securities held by Abingworth Bioventures VII, LP, and therefore no longer reports those securities on his Section 16 reports.